← Leaderboards
Rakesh K. Sindhi
Children'S Hosp Pittsburgh/Upmc Hlth Sys
$3,236,424
Attributed
$4,829,599
Total exposure
8
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $657K · FY2005–20$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$4,829,599 · 8
By mechanism
R01$4,793,791 · 3
M01$35,808 · 5
Top collaborators
- Donghun Shin4 shared
- Shankar Subramaniam4 shared
Most similar at Children'S Hosp Pittsburgh/Upmc Hlth Sys
Same institution · by research overlap
- Lakshmanan Krishnamurti$5,191,890
Others in their field
Top investigators on “Liver Transplantation”
- John C Magee · University Of Michigan At Ann Arbor$32,824,292
- Robert M Merion · University Of Michigan At Ann Arbor$32,380,845
- Jeffrey S Glenn · Stanford University$29,122,918
- Peter G Stock · University Of California San Francisco$27,203,354
- William M Lee · University Of Texas Sw Med Ctr/Dallas$24,215,692
- Dorry Segev · Johns Hopkins University$23,097,210
Research focus
Liver TransplantationHuman SubjectSirolimusFk506LymphocyteFlow CytometryTransplantationResponseBiomarkerPathway InteractionsGenesOrganPatternSamplingChildCandidate Disease GeneClinical ResearchChildhoodCohortGene FunctionBiologicalSingle Nucleotide PolymorphismHuman Therapy EvaluationArtificial Immunosuppression
Grant awards (21)
Mapping Disease Pathways for Biliary Atresia$504,232
R01 · FY2020 · DK · contact PI
Mapping Disease Pathways for Biliary Atresia$592,433
R01 · FY2019 · DK · contact PI
Mapping Disease Pathways for Biliary Atresia$636,062
R01 · FY2018 · DK · contact PI
Mapping Disease Pathways for Biliary Atresia$657,036
R01 · FY2017 · DK · contact PI
Predictors for drug selection and minimization in pediatric liver transplantation$393,604
R01 · FY2009 · AI · contact PI
Predictors for drug selection and minimization in pediatric liver transplantation$344,236
R01 · FY2008 · AI · contact PI
Predictors for drug selection and minimization in pediatric liver transplantation$350,830
R01 · FY2007 · AI · contact PI
Predictors for drug selection and minimization in pediatric liver transplantation$372,108
R01 · FY2006 · AI · contact PI
PHARMACOKINETICS OF SIROLIMUS CONVERSION IN PEDIATRIC LIVER TRANSPLANT$11,957
M01 · FY2005 · RR
PHARMACODYNAMIC THRESHOLDS OF IMMUNOSUPPRESSION$5,315
M01 · FY2005 · RR
STEROID-FREE IMMUNOSUPRESSION WITH SIROLIUMS &TACROLIMUS IN PRIMARY PEDIATRIC$3,189
M01 · FY2005 · RR
Pharmacodynamic Thresholds of Immunosuppression$245,000
R01 · FY2004 · AI
Pharmacodynamic Thresholds of Immunosuppression$10,042
M01 · FY2004 · RR
Steroid-Free Immunosupression with Sirolimus &Tacrolimu$5,116
M01 · FY2004 · RR
Pharmacodynamic Thresholds of Immunosuppression in Transplant Recipients$189
M01 · FY2004 · RR
Pharmacodynamic Thresholds of Immunosuppression$245,000
R01 · FY2003 · AI
Pharmacodynamic Thresholds of Immunosuppression$232,750
R01 · FY2002 · AI
Pharmacologic thresholds for safe immunosuppression$0
M01 · FY2002 · RR
Pharmacodynamic Thresholds of Immunosuppression$220,500
R01 · FY2001 · AI
Pharmacologic thresholds for safe immunosuppression$0
M01 · FY2001 · RR
Pharmacologic thresholds for safe immunosuppression$0
M01 · FY2000 · RR